Home » Topics » Regulatory

Regulatory
RSS

Ranexa approved for chronic angina

Jan. 30, 2006

Exubera approved in Europe and the U.S.

Jan. 30, 2006

Sutent approved for advanced renal cell carcinoma and malignant GIST

Jan. 30, 2006

Japanese approval for Urief

Jan. 24, 2006

FDA approval for subcutaneous immunoglobulin treatment Vivaglobin

Jan. 11, 2006

Climara Pro approved for prevention of postmenopausal osteoporosis

Jan. 9, 2006

FDA approval for Vaprisol in euvolemic hyponatremia

Jan. 2, 2006

Femara receives new U.S. approval

Dec. 30, 2005

Revlimid receives FDA approval

Dec. 29, 2005

Orencia approved for rheumatoid arthritis

Dec. 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...